Difficulty: Medium
Average Score: 92%
Practice
Patient with renal failure is undergoing periodic hemodialysis while awaiting a transplant. Between dialysis sessions we want to reduce the body's phosphate load by reducing dietary phosphate absorption and removing some phosphate already in the blood. Which of the following drugs would be most suitable for this purpose?
Correct answer
A
Rationale
In a patient with renal failure undergoing hemodialysis, managing phosphate levels is crucial to prevent complications associated with hyperphosphatemia. The most suitable drug among the options provided is A) Aluminum hydroxide gel.
Aluminum hydroxide gel functions as a phosphate binder by binding dietary phosphate in the gastrointestinal tract, thereby reducing its absorption. Additionally, aluminum is partially absorbed into the bloodstream and can bind with phosphate already in the blood, aiding in its removal during dialysis sessions. This dual mechanism makes it an effective choice in managing phosphate levels in patients with renal failure.
Now, let's discuss why the other options are not the most suitable in this scenario:
B) Bismuth subsalicylate: Primarily used for treating gastrointestinal issues like diarrhea and indigestion, it does not have a specific mechanism to bind phosphate and reduce absorption.
C) Magnesium hydroxide/oxide: These compounds are primarily used as antacids to neutralize stomach acid and relieve heartburn. They do not have a significant impact on phosphate binding or removal.
D) Sodium bicarbonate: Used to treat conditions like acidosis, sodium bicarbonate does not directly target phosphate levels in the body.
Educationally, understanding the pharmacological actions of drugs affecting the gastrointestinal system is vital for healthcare professionals managing patients with renal failure. Knowledge of drug mechanisms and their applications in specific patient populations ensures safe and effective treatment interventions. Aluminum hydroxide gel's unique ability to bind dietary phosphate and aid in its removal makes it the most appropriate choice in this clinical scenario.
Aluminum hydroxide gel functions as a phosphate binder by binding dietary phosphate in the gastrointestinal tract, thereby reducing its absorption. Additionally, aluminum is partially absorbed into the bloodstream and can bind with phosphate already in the blood, aiding in its removal during dialysis sessions. This dual mechanism makes it an effective choice in managing phosphate levels in patients with renal failure.
Now, let's discuss why the other options are not the most suitable in this scenario:
B) Bismuth subsalicylate: Primarily used for treating gastrointestinal issues like diarrhea and indigestion, it does not have a specific mechanism to bind phosphate and reduce absorption.
C) Magnesium hydroxide/oxide: These compounds are primarily used as antacids to neutralize stomach acid and relieve heartburn. They do not have a significant impact on phosphate binding or removal.
D) Sodium bicarbonate: Used to treat conditions like acidosis, sodium bicarbonate does not directly target phosphate levels in the body.
Educationally, understanding the pharmacological actions of drugs affecting the gastrointestinal system is vital for healthcare professionals managing patients with renal failure. Knowledge of drug mechanisms and their applications in specific patient populations ensures safe and effective treatment interventions. Aluminum hydroxide gel's unique ability to bind dietary phosphate and aid in its removal makes it the most appropriate choice in this clinical scenario.